Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2011

Feb 25, 2011

30145_dirs_2011-02-25_bdbbbe16-3687-4d41-aa83-c160ec57b8cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2011-02-23

Reporting Person: McCulley Steven E (Vice President & Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-23 Humana Common M 11784 $32.70 Acquired 36095 Direct
2011-02-23 Humana Common M 7709 $53.96 Acquired 43804 Direct
2011-02-23 Humana Common S 14582 $63.2427 Disposed 29222 Direct
2011-02-24 Humana Common S 14000 $62.8225 Disposed 15222 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-23 Options $32.70 M 11784 Disposed 2012-02-24 Humana Common (11784) Direct
2011-02-23 Options $53.96 M 7709 Disposed 2013-02-23 Humana Common (7709) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 692 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $62.10 2014-02-22 Humana Common (8110) 8110 Direct
Options $69.475 2015-02-21 Humana Common (6839) 6839 Direct
Options $45.975 2015-04-01 Humana Common (20992) 20992 Direct
Options $41.83 2016-02-19 Humana Common (9998) 9998 Direct
Restricted Stock Units $ Humana Common (3879) 3879 Direct
Restricted Stock Units $ Humana Common (8990) 8990 Direct
Phantom Stock Units $ Humana Common (7) 7 Indirect

Footnotes

F1: The shares sold in multiple lots ranging from $63.2288 to $63.29 The weighted average sale price was $63.2427

F2: The shares sold in multiple lots ranging from $62.79 to $62.851. The weighted average sale price was $62.8225.

F3: Stock units held for the benefit of reporting person as of January 31, 2011 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).

F4: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan.

F5: Incentive and Non-Qualified stock options granted to reporting person on 2/24/05, both vesting in three increments from 2/24/06 to 2/24/08.

F6: Incentive and Non-Qualified stock options granted to reporting person on 2/23/06, NQ options vesting in three increments from 2/23/07 to 2/23/09, and ISO's vesting on 2/23/09.

F7: Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.

F8: Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.

F9: Incentive and Non-Qualified stock options granted to reporting person on 4/1/08, NQ options vesting in three increments from 4/1/11 to 4/1/13, and ISO's vesting in two increments on 4/1/12 and 4/1/13.

F10: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.

F11: Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.

F12: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F13: Restricted stock units granted to reporting person on 2/18/10, 100% of the award is vesting on 2/18/13.

F14: Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.

F15: Phantom Stock Units held for the benefit of reporting person as of January 31, 2011 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Excess Plan exempt under Rule 16b-3(c and d).